0001246360-14-003136.txt : 20140702
0001246360-14-003136.hdr.sgml : 20140702
20140702175612
ACCESSION NUMBER: 0001246360-14-003136
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140630
FILED AS OF DATE: 20140702
DATE AS OF CHANGE: 20140702
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SYNAGEVA BIOPHARMA CORP
CENTRAL INDEX KEY: 0000911326
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 561808663
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 33 HAYDEN AVE.
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: (781) 357-9900
MAIL ADDRESS:
STREET 1: 33 HAYDEN AVE.
CITY: LEXINGTON
STATE: MA
ZIP: 02421
FORMER COMPANY:
FORMER CONFORMED NAME: TRIMERIS INC
DATE OF NAME CHANGE: 19970516
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Quinn Anthony
CENTRAL INDEX KEY: 0001532219
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23155
FILM NUMBER: 14958022
MAIL ADDRESS:
STREET 1: 128 SPRING STREET, SUITE 520
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
form.xml
PRIMARY DOCUMENT
X0306
4
2014-06-30
false
0000911326
SYNAGEVA BIOPHARMA CORP
GEVA
0001532219
Quinn Anthony
33 HAYDEN AVE
LEXINGTON
MA
02421
false
true
false
false
EVP, CMO & Head of R&D
Common Stock
2014-06-30
4
A
false
71
54.89
A
25595
D
The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the Synageva BioPharma Corp. Employee Stock Purchase Plan ("ESPP"), for the option period of January 1, 2014 through June 30, 2014 (the "Option Period"). This transaction is also exempt under Rule 16b-3(c).
The transaction occurred on the last day of the Option Period.
In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on January 2, 2014, the first trading day of the Option Period.
/s/ Anthony Quinn
2014-07-02